2023 ACR/EULAR antiphospholipid syndrome classification criteria
Medha Barbhaiya, Stéphane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Mary‐Carmen Amigo, Zahir Amoura, DANIELI CASTRO OLIVEIRA DE ANDRADE, Laura Andréoli, Bahar Artım-Esen, Tatsuya Atsumi, Tadej Avčin · 2023
Read 2023 ACR/EULAR antiphospholipid syndrome classification criteria by Medha Barbhaiya, Stéphane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Mary‐Carmen Amigo, Zahir Amoura, DANIELI CASTRO OLIVEIRA DE ANDRADE, Laura Andréoli, Bahar Artım-Esen, Tatsuya Atsumi, Tadej Avčin (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w4386220262.txt.
Description
Medha Barbhaiya, Stéphane Zuily, Ray Naden, and colleagues present the 2023 classification criteria for antiphospholipid syndrome, in the Annals of the Rheumatic Diseases. The syndrome, shortened to APS, makes blood clot too readily and complicates pregnancy. Classification criteria define who counts as having APS in studies and trials. The American College of Rheumatology and EULAR backed this joint effort to sharpen them.
The team built the criteria in four phases, from literature review and surveys to expert voting and validation. Patients enter the scheme only with a positive antibody test close in time to a relevant symptom. Weighted points then accrue across six clinical and two laboratory domains. Reaching set scores in both sides classifies a patient as having APS for research.
Catalog record
| CREATOR | Medha Barbhaiya, Stéphane Zuily, Ray Naden, Alison Hendry, Florian Manneville, Mary‐Carmen Amigo, Zahir Amoura, DANIELI CASTRO OLIVEIRA DE ANDRADE, Laura Andréoli, Bahar Artım-Esen, Tatsuya Atsumi, Tadej Avčin |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 90 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Annals of the Rheumatic Diseases |